Dark Forest Capital Management’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$865K Buy
+21,449
New +$802K 0.08% 411
2025
Q3
Sell
-3,379
Closed -$248K 1212
2025
Q2
$248K Buy
3,379
+205
+6% +$14.9K 0.01% 1055
2025
Q1
$363K Buy
+3,174
New +$193K 0.02% 1017
2024
Q4
Sell
-6,156
Closed -$285K 1004
2024
Q3
$285K Buy
+6,156
New +$219K 0.04% 655
2023
Q4
Sell
-19,384
Closed -$528K 595
2023
Q3
$528K Buy
+19,384
New +$561K 0.04% 695
2023
Q1
Sell
-1,524
Closed -$31K 1214
2022
Q4
$31K Buy
+1,524
New +$38.2K 0.01% 476
2021
Q3
Sell
-10,064
Closed -$221K 1307
2021
Q2
$221K Buy
+10,064
New +$224K 0.1% 158

Other funds holding CORT

Dark Forest Capital Management's CORT Position: Q1 2026 in Review

Dark Forest Capital Management opened a new position in Corcept Therapeutics (CORT) in Q1 2026: 21,449 shares worth $865K. The stake represents 0.08% of the portfolio and ranks #411 among its holdings. This is a return to the name: Dark Forest Capital Management previously reported a position in CORT as recently as Q2 2025.

Dark Forest Capital Management first reported a position in CORT in Q2 2021 and has held it in 7 quarters since. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

  • Dark Forest Capital Management held 21,449 shares of Corcept Therapeutics worth $865K as of Q1 2026.
  • Corcept Therapeutics was a new Dark Forest Capital Management position in Q1 2026.
  • Corcept Therapeutics made up 0.08% of Dark Forest Capital Management's portfolio in Q1 2026, its #411 holding.
  • Dark Forest Capital Management first reported a position in Corcept Therapeutics in Q2 2021 and has held it in 7 quarters since.
  • 351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.